Bayer planning to hold online-only stockholders ’ meeting on April 28, 2020
Stockholders able to exercise right to submit questions and cast votes in a timely manner / Online stockholders’ meeting enables proposed dividend of 2.80 euros per share for 2019 to be paid on time and in full / Baumann:“Reliability for our stockholders is very important, especially during the crisis” (Source: Bayer Company News)
Source: Bayer Company News - March 27, 2020 Category: Pharmaceuticals Source Type: news
Bayer announces five late-breaking presentations which include data from VICTORIA (vericiguat) and VOYAGER PAD (Xarelto ™ ) Phase III studies (for specialized target groups only)
The VICTORIA study provides insight into the efficacy of vericiguat, the first soluble guanylate cyclase (sGC) stimulator investigated in patients with chronic heart failure following a worsening event / The VOYAGER PAD study investigated the use of Xarelto 2.5 mg twice daily plus aspirin 100 mg once daily in patients with symptomatic peripheral artery disease (PAD) post peripheral revascularization / Five late-breaking abstracts have been accepted for presentation and demonstrate Bayer’s ongoing commitment to the treatment of cardiovascular disease (Source: Bayer Company News)
Source: Bayer Company News - March 20, 2020 Category: Pharmaceuticals Source Type: news
Bayer donates one million euros for hospitals in Lombardy
Chairman of the Board of Management, Baumann:“Our emergency aid is designed to help support hospitals and hospital staff during the crisis.” (Source: Bayer Company News)
Source: Bayer Company News - March 18, 2020 Category: Pharmaceuticals Source Type: news
Bayer strategically and operationally successful
Group sales advance by 3.5 percent (Fx& portfolio adj.) to 43.545 billion euros / EBITDA before special items increases by 28.3 percent to 11.503 billion euros / Core earnings per share up by 14.3 percent to 6.40 euros / Net income rises 141.4 percent to 4.091 billion euros– gain of 1.637 billion euros on sale of Currenta stake / Free cash flow of 4.214 billion euros above expectations / Proposed dividend of 2.80 euros per share / Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business / Pharmaceuticals shows encouraging business development / Sales g...
Source: Bayer Company News - February 27, 2020 Category: Pharmaceuticals Source Type: news
Norbert Winkeljohann to succeed Werner Wenning as Chairman of Bayer ’ s Supervisory Board
Werner Wenning to retire after over 50 years with Bayer / Horst Baier proposed for election as new shareholder representative (Source: Bayer Company News)
Source: Bayer Company News - February 26, 2020 Category: Pharmaceuticals Source Type: news
Bayer and Nuvisan create new research unit in Berlin
Nuvisan to establish full-fledged research center with around 400 jobs in Berlin / Transaction to contribute to further strengthening healthcare cluster in Berlin / Bayer to retain significant research activities and headquarters for the company’s Pharmaceuticals Division in Berlin (Source: Bayer Company News)
Source: Bayer Company News - February 11, 2020 Category: Pharmaceuticals Source Type: news
CDP again rates Bayer as one of the leading international companies for water management
Top assessment for 10 years in succession / Bayer only DAX company with best rating both in climate change and water security (Source: Bayer Company News)
Source: Bayer Company News - February 3, 2020 Category: Pharmaceuticals Source Type: news
Bayer application for nifurtimox to treat pediatric patients with Chagas disease submitted for approval in US
New formulation for weight-adjusted treatment of pediatric Chagas patients age 0-18 targets most vulnerable patient group / Submission based on results of CHICO (CHagas disease In Children treated with NifurtimOx) phase III clinical study of nifurtimox in pediatric patients with Chagas disease as well as pre-clinical data / Fight against Neglected Tropical Diseases part of Bayer’s Sustainability Strategy (Source: Bayer Company News)
Source: Bayer Company News - January 30, 2020 Category: Pharmaceuticals Source Type: news
Darolutamide plus androgen deprivation therapy significantly increased overall survival in men with non-metastatic castration-resistant prostate cancer (for specialized target groups only)
Full data to be presented at upcoming scientific meeting (Source: Bayer Company News)
Source: Bayer Company News - January 30, 2020 Category: Pharmaceuticals Source Type: news
Bayer to donate medicines and money with a total value of approximately EUR 1.5 million
CEO Werner Baumann:“We want to help people in the affected regions quickly and effectively” (Source: Bayer Company News)
Source: Bayer Company News - January 28, 2020 Category: Pharmaceuticals Source Type: news
Bayer submits application to European Medicines Agency for pre-filled syringe to administer eye medication Eylea ® (for specialized target groups only)
(Source: Bayer Company News)
Source: Bayer Company News - January 23, 2020 Category: Pharmaceuticals Source Type: news
Bayer receives approval for darolutamide in Japan (for specialized target groups only)
Marketing authorization granted for the treatment of men with non-metastatic castration-resistant prostate cancer (Source: Bayer Company News)
Source: Bayer Company News - January 23, 2020 Category: Pharmaceuticals Source Type: news
Bayer and Dar é Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene® (for specialized target groups only)
Underlining Bayer’s commitment in the field of women’s health / Potential commercial milestone payments of up to USD 310 million and tiered royalties on net sales in the double-digit range (Source: Bayer Company News)
Source: Bayer Company News - January 13, 2020 Category: Pharmaceuticals Source Type: news
Bayer to significantly step-up its sustainability efforts
2030 target to be carbon neutral in own operations / Ambitious 2030 objectives for access to health and nutrition in low- and middle-income countries and underserved communities / Measurable sustainability targets to be incorporated into management compensation (Source: Bayer Company News)
Source: Bayer Company News - December 10, 2019 Category: Pharmaceuticals Source Type: news
